Rush Scientists Develop Potential COVID-19 DrugJanuary 20, 2021
Scientists from Rush University Medical Center in Chicago, Illinois have developed a new potential therapy for COVID-19 that has shown promising results in its lab study.
The scientists used hexapeptide in mouse models that are infected with COVID-19. The peptide was nasally introduced and has shown to be effective in reducing fever, improving heart function, protecting the lungs, and reversing cytokine storm. The peptide is also successful in preventing the progression of the disease. Cytokine storm is the overreacting of the immune system to infection by overflooding the bloodstream with inflammatory proteins. This peptide inhibits cytokines produced by COVID-19.
The discovery of this drug will be a great help in controlling the virus transmission even in the post-vaccine era because vaccines alone do not guarantee total prevention of the spread of the virus.
For more details, read the article in Rush.
You might also like:
- Pocket K No. 58: COVID-19 Treatment Efforts Using Plant Technologies
- The Role of Plant Biotechnology Against SARS-CoV-2
- COVID-19 Treatment Efforts Using Plant Technologies
Biotech Updates is a weekly newsletter of ISAAA, a not-for-profit organization. It is distributed for free to over 22,000 subscribers worldwide to inform them about the key developments in biosciences, especially in biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
See more articles:
News from Around the World
- FAO Promotes Innovation to Maintain Agri-Food Systems During the COVID-19 Pandemic
- Dr. Margaret Karembu Conferred Moran of the Order of the Burning Spear (MBS) by Kenyan President
- Camelina Plants Engineered to Produce Pheromones for Pest Control
- USDA APHIS Deregulates GE Insect Resistant Cotton
- Gene Editing Provides Possible Solution to Citrus Greening Disease
- USDA, FDA Sign MOU on Animal Biotechnology Regulation
- FSANZ Calls for Comment for GM Food Derived from Herbicide Tolerant Canola
- EFSA Publishes Scientific Opinion on Four-Event Stack Maize 1507 × MIR162 × MON810 × NK603
- Scientists Propose to Use Genetic Engineering to Develop Fusarium Wilt-Resistant Bananas
- France: "NBTs are not GMOs"
- Improving Biotic Tolerance in Crop Plants through Gene Editing
- Rush Scientists Develop Potential COVID-19 Drug
Read the latest:
- Biotech Updates (June 7, 2023)
- Gene Editing Supplement (May 31, 2023)
- Gene Drive Supplement (February 22, 2023)
Subscribe to BU: